Article citationsMore>>

J. P. Pignon, N. Syz, M. Posner, R. Olivares, L. Le Lann, A. Yver, et al., “Adjusting for Patient Selection Suggests the Addition of Docetaxel to 5-Fluorouracil-Cisplatin Induction Therapy May Offer Survival Benefit in Squamous Cell Cancer of the Head and Neck,” Anticancer Drugs, Vol. 15, No. 4, 2004, pp. 331-340.
http://dx.doi.org/10.1097/00001813-200404000-00004

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top